Loading cancer entity…
Loading cancer entity…
Clinical trials
28 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04106843 | Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 7, 2020 | clinicaltrials |
| NCT02381925 | Multicenter Registry Comparing Preoperative Imaging for Primary Hyperparathyroidism | withdrawn | — | 0 | Duke UniversityOTHER | 0 | Sep 21, 2015 | clinicaltrials |
Data updated 22 days agoSource updated Sep 7, 2020source: clinicaltrials